Rise Gold discloses option and DSU grants to executives and directors
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Rise Gold Corp. reported unregistered sales of securities tied to compensation. The company granted 1,445,469 stock options to directors and officers at an exercise price of $0.25 per share, expiring on October 30, 2030, and issued 1,365,854 deferred share units (DSUs) under its Long‑Term Incentive Plan, relying on Section 4(a)(2) of the Securities Act.
Allocations included 530,469 options and 1,000,000 DSUs to President & CEO Joseph Mullin, and 75,000 options to CFO Mihai Draguleasa. A related press release was filed as Exhibit 99.1.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 3.02, 5.02, 9.01
3 items
Item 3.02
Unregistered Sales of Equity Securities
Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did RYES disclose in its 8-K?
Rise Gold granted 1,445,469 stock options at $0.25 per share expiring October 30, 2030, and 1,365,854 DSUs to directors and officers.
Which exemption did RYES rely on for these grants?
The company relied on Section 4(a)(2) of the Securities Act for a private offering exemption.
How many awards did the RYES CEO receive?
President & CEO Joseph Mullin received 530,469 stock options and 1,000,000 DSUs.
What awards did the RYES CFO receive?
CFO Mihai Draguleasa received 75,000 stock options.
What is the exercise price and term of the options?
The options are exercisable at $0.25 per share until October 30, 2030.
Was an exhibit provided with more details?
Yes. A press release dated October 30, 2025 was filed as Exhibit 99.1.